Japan, April 17 -- BLUEFIN BIOMEDICINE INC has got intellectual property rights for 'ANTI-CUB DOMAIN-CONTAINING PROTEIN 1 (CDCP1) ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF USE THEREOF.' Other related details are as follows:
Application Number: JP,2023-203139
Category (FI): A61K31/537,A61P35/00,A61K47/68,A61K39/395@L,C12N15/13,C07K16/28,A61K39/395@T,A61K38/07
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Nov. 30, 2023
Publication Date: Feb. 28, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
